46445
UNIAO QUIMICA FARMACEUTICA NACIONAL SA
Aug 26, 2022
Brazil
Latin America and the Caribbean
Oct 14, 2022
B - Limited
Active
Jun 9, 2023
Regional Industry MAS LAC & EUR
other
Approved : Nov 2, 2022
Signed : Feb 2, 2023
Invested : Jun 5, 2023
other
The proposed investment entails an up to US$65 million A loan in BRL equivalent to União Química Farmacêutica Nacional S.A. (“UQ” or the “Company”), a life science manufacturing company headquartered in Brazil. The proceeds will be used to (i) expand production capacity with a focus on antibiotics, corticoids, anti-inflammatories, anesthetics, and others serving the hospital segment which had a spike in demand due to COVID-19 and supply disruptions; (ii) upgrade two existing plants to produce vaccines (both for COVID-19 and other uses); and (iii) finance working capital needs (all investments together are defined as the “Project”).
With over 85 years of operations, the Company has grown into a diversified pharmaceutical manufacturer for human health (prescription drugs and OTC for retail and hospital clients), animal health and toll manufacturing.
IFC will provide advisory support to União Química to help them in two key aspects i) increasing access to vaccines in the region by advising on the expansion of their vaccines capabilities and ii) evaluating energy efficiency and decarbonization opportunities.
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation
Fernando de Souza
Financial Manager
Av. Magalhaes de Castro, n° 4.800,
Conjuntos 161/162, Edificio Continental
Towe – Cidade Jardim São Paulo-SP, Brazil
Email: fersouza@uniaoquimica.com.br
www.uniaoquimica.com.br/en/home-en/